Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BorrSci: Two vs six weeks doxycycline for Lyme neuroborreliosis
2015-001481-25Phase 3Completed
- Sponsor
- Sørlandet sykehus
- Start
- Aug 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of doxycycline in Lyme disease (2 arms), sponsored by Sørlandet sykehus. Primary endpoint: Composite clinical score. Started Aug 2015; status: completed.
02
Drugs
doxycycline
03
Conditions
Lyme disease
Beyond the preview
Go deeper on 2015-001481-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-001481-25.